|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Sage Therapeutics, Inc. (SAGE) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
58,290,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sage Therapeutics is a biopharmaceutical company focused on developing and commercializing medicines with the potential to transform the lives of people with debilitating disorders of the brain. Co.'s principal product, ZULRESSO, is a proprietary intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. Co.'s other product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder, and PPD. Co. has a portfolio of other compounds that target GABAA receptors, including SAGE-324. SAGE-324 is a GABAA receptor positive allosteric modulator intended for chronic oral dosing.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
3,000 |
25,500 |
Total Buy Value |
$0 |
$0 |
$87,779 |
$839,364 |
Total People Bought |
0 |
0 |
1 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
4 |
Total Shares Sold |
0 |
0 |
0 |
11,643 |
Total Sell Value |
$0 |
$0 |
$0 |
$519,413 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Robichaud Albert |
Chief Scientific Officer |
|
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,375 |
146,680 |
|
- |
|
Jonas Jeffrey M |
|
|
2023-02-03 |
4 |
D |
$44.16 |
$63,016 |
D/D |
(1,427) |
121,981 |
|
- |
|
Jonas Jeffrey M |
|
|
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,100 |
123,408 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2023-01-09 |
4 |
OE |
$1.36 |
$2,176 |
D/D |
1,600 |
59,624 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2023-01-04 |
4 |
OE |
$1.36 |
$2,448 |
D/D |
1,800 |
58,024 |
|
- |
|
Jonas Jeffrey M |
|
|
2023-01-03 |
4 |
OE |
$28.63 |
$71,604 |
D/D |
2,501 |
118,308 |
|
- |
|
Paul Steven M |
|
|
2022-11-28 |
4 |
A |
$38.17 |
$191 |
I/I |
5 |
78,539 |
|
- |
|
Greene Barry E |
President and CEO |
|
2022-11-10 |
4 |
B |
$34.48 |
$500,022 |
D/D |
14,500 |
46,940 |
0.01 |
- |
|
Golumbeski George |
|
|
2022-05-05 |
4 |
B |
$31.45 |
$251,563 |
D/D |
8,000 |
8,000 |
0.01 |
- |
|
Jonas Jeffrey M |
|
|
2022-04-27 |
4 |
OE |
$0.45 |
$13,925 |
D/D |
30,944 |
115,807 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2022-02-17 |
4 |
OE |
$1.36 |
$6,120 |
D/D |
4,500 |
55,600 |
|
- |
|
Jonas Jeffrey M |
Chief Innovation Officer |
|
2022-02-17 |
4 |
OE |
$0.45 |
$1,800 |
D/D |
4,000 |
84,863 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2021-11-23 |
4 |
OE |
$1.36 |
$1,360 |
D/D |
1,000 |
51,100 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2021-11-22 |
4 |
OE |
$1.36 |
$3,400 |
D/D |
2,500 |
50,100 |
|
- |
|
Paul Steven M |
|
|
2021-11-09 |
4 |
A |
$43.36 |
$43 |
I/I |
1 |
1 |
|
- |
|
Kanes Stephen |
Chief Medical Officer |
|
2021-10-19 |
4 |
D |
$40.29 |
$45,125 |
D/D |
(1,120) |
13,471 |
|
- |
|
Kanes Stephen |
Chief Medical Officer |
|
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
14,591 |
|
- |
|
Cook Anne Marie |
SVP, GC & Secretary |
|
2021-10-19 |
4 |
D |
$40.29 |
$44,964 |
D/D |
(1,116) |
7,894 |
|
- |
|
Cook Anne Marie |
SVP, GC & Secretary |
|
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
9,010 |
|
- |
|
Robichaud Albert |
Chief Scientific Officer |
|
2021-10-19 |
4 |
D |
$40.29 |
$44,964 |
D/D |
(1,116) |
142,619 |
|
- |
|
Robichaud Albert |
Chief Scientific Officer |
|
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
143,735 |
|
- |
|
Jonas Jeffrey M |
Chief Innovation Officer |
|
2021-10-19 |
4 |
D |
$40.29 |
$176,228 |
D/D |
(4,374) |
80,863 |
|
- |
|
Jonas Jeffrey M |
Chief Innovation Officer |
|
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
85,237 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2021-10-19 |
4 |
D |
$40.29 |
$41,257 |
D/D |
(1,024) |
47,600 |
|
- |
|
Iguchi Kimi |
CFO & Treasurer |
|
2021-10-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,800 |
48,624 |
|
- |
|
261 Records found
|
|
Page 2 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|